Stay updated on Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:57:30.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to the efficacy and safety evaluation of tislelizumab as a second-line treatment for participants with advanced esophageal squamous cell carcinoma.
    Difference
    0.1%
    Check dated 2024-06-06T14:29:09.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participants, specifying the need for a histologically confirmed diagnosis of esophageal squamous cell carcinoma (ESCC) and tumor progression during or after first-line treatment for advanced unresectable/metastatic ESCC. Previously, no information was provided under Participation Criteria Collaborators and Investigators.
    Difference
    16%
    Check dated 2024-05-22T20:59:17.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:14:57.000Z thumbnail image

Stay in the know with updates to Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page.